£65.36

Inhaled Treatment of Respiratory Infections

Other Branches of Medicine

Price data last checked 23 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£65 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 68 days • 1 price levels

Days at Price

Price Analysis

Most common price: £65 (68 days, 100.0%)

Price range: £65 - £65

Price levels: 1 different prices over 68 days

Description

Respiratory infections are conventionally treated with oral or intravenous antimicrobials (antivirals, antibiotics, and antifungals). However, these routes of administration are not ideal because the required drugs are systemically delivered rather than being targeted to the respiratory tract. Higher doses may also be needed to achieve sufficient drug concentrations in the lungs, which may consequently increase the risk of adverse effects. On the other hand, the drugs can be efficiently delivered into the airways as inhaled aerosols. Lower doses can then be used to attain relatively high local concentrations. There are specific challenges to the development of inhaled formulations, such as the optimisation of their physicochemical stability and aerosol performance. In addition, antimicrobial resistance is an urgent global public health issue. Novel strategies are required to overcome these problems. The papers in this reprint focus on recent advancements in inhaled antimicrobials and vaccines, including those for viral (SARS‑CoV‑2), bacterial (Mycobacterium tuberculosis, Mycoplasma pneumoniae, Acinetobacter baumanii), and fungal infections (moulds).

Product Specifications

Format: hardcover
ASIN: 3725803927
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain: Amazon UK
Release Date: 14 February 2024
Listed Since: 04 March 2024

Barcode

No barcode data available

Inhaled Treatment of Respiratory Infections

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Advances in Infectious Diseases and Clinical Microbiology during and after the COVID-19 Pandemic: 2nd Edition

Challenges and Future Prospects of Antibacterial Therapy

Pulmonary Infection: 857 (Advances in Experimental Medicine and Biology, 857)

Antimicrobial and Anti-Infective Activity of Natural Products, 2nd Edition

Cavitation-Enhanced Drug Delivery and Immunotherapy

Fungal Infections in Intensive Care Medicine

Nanostructures for Antimicrobial and Antibiofilm Applications (Nanotechnology in the Life Sciences)

Nanostructures for Antimicrobial and Antibiofilm Applications (Nanotechnology in the Life Sciences)

COVID-19 Prevention and Treatment

Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria

New Challenges in Mathematical Modelling and Control of COVID-19 Epidemics: Analysis of Non-pharmaceutical Actions and Vaccination Strategies

Antimicrobial Prescribing and Stewardship, 2nd Volume

Novel Approaches for Overcoming Biological Barriers

Influenza and Respiratory Care: 968 (Advances in Experimental Medicine and Biology, 968)

Respiratory Virology and Immunogenicity: 836 (Advances in Experimental Medicine and Biology, 836)

Innate Immunity to Virus Infection 2023

Inflammatory Disorders: 839 (Advances in Experimental Medicine and Biology, 839)

Antimicrobial and Anti-infective Activity of Natural Products

Emerging Modalities in Mitigation of Antimicrobial Resistance

Influence of Natural and/or Vaccine Immunity on the Dynamics of SARS-CoV-2

Nano-Antimicrobials: Progress and Prospects

Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance

Mental Health Challenges during the COVID-19 Pandemic

Inhalation Aerosols: Physical and Biological Basis for Therapy, Third Edition: 1 (Lung Biology in Health and Disease)